H10.13 Acute atopic conjunctivitis, bilateral
H10.12 Acute atopic conjunctivitis, left eye
H10.11 Acute atopic conjunctivitis, right eye
J01.20 Acute ethmoidal sinusitis, unspecified
H68.013 Acute Eustachian salpingitis, bilateral
H68.012 Acute Eustachian salpingitis, left ear
H68.011 Acute Eustachian salpingitis, right ear
J01.10 Acute frontal sinusitis, unspecified
J04.0 Acute laryngitis
J01.00 Acute maxillary sinusitis, unspecified
J05.0 Acute obstructive laryngitis [croup]
J01.40 Acute pansinusitis, unspecified
J01.21 Acute recurrent ethmoidal sinusitis
J01.11 Acute recurrent frontal sinusitis
J01.01 Acute recurrent maxillary sinusitis
J01.41 Acute recurrent pansinusitis
J01.91 Acute recurrent sinusitis, unspecified
J01.31 Acute recurrent sphenoidal sinusitis
H65.03 Acute serous otitis media, bilateral
H65.02 Acute serous otitis media, left ear
H65.06 Acute serous otitis media, recurrent, bilateral
H65.05 Acute serous otitis media, recurrent, left ear
H65.04 Acute serous otitis media, recurrent, right ear
H65.01 Acute serous otitis media, right ear
J01.90 Acute sinusitis, unspecified
J01.30 Acute sphenoidal sinusitis, unspecified
T39.1X5A Adverse effect of 4-Aminophenol derivatives, initial encounter
T39.1X5S Adverse effect of 4-Aminophenol derivatives, sequela
T39.1X5D Adverse effect of 4-Aminophenol derivatives, subsequent encounter
T44.6X5A Adverse effect of alpha-adrenoreceptor antagonists, initial encounter
T44.6X5S Adverse effect of alpha-adrenoreceptor antagonists, sequela
T44.6X5D Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter
T36.5X5A Adverse effect of aminoglycosides, initial encounter
T36.5X5S Adverse effect of aminoglycosides, sequela
T36.5X5D Adverse effect of aminoglycosides, subsequent encounter
T43.625A Adverse effect of amphetamines, initial encounter
T43.625S Adverse effect of amphetamines, sequela
T43.625D Adverse effect of amphetamines, subsequent encounter
T50.7X5A Adverse effect of analeptics and opioid receptor antagonists, initial encounter
T50.7X5S Adverse effect of analeptics and opioid receptor antagonists, sequela
T50.7X5D Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter
T38.7X5A Adverse effect of androgens and anabolic congeners, initial encounter
T38.7X5S Adverse effect of androgens and anabolic congeners, sequela
T38.7X5D Adverse effect of androgens and anabolic congeners, subsequent encounter
T46.4X5A Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T46.4X5S Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
T46.4X5D Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
T38.815A Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
T38.815S Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
T38.815D Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
T37.4X5A Adverse effect of anthelminthics, initial encounter
T37.4X5S Adverse effect of anthelminthics, sequela
T37.4X5D Adverse effect of anthelminthics, subsequent encounter
T45.0X5A Adverse effect of antiallergic and antiemetic drugs, initial encounter
T45.0X5S Adverse effect of antiallergic and antiemetic drugs, sequela
T45.0X5D Adverse effect of antiallergic and antiemetic drugs, subsequent encounter
T48.6X5A Adverse effect of antiasthmatics, initial encounter
T48.6X5S Adverse effect of antiasthmatics, sequela
T48.6X5D Adverse effect of antiasthmatics, subsequent encounter
T44.0X5A Adverse effect of anticholinesterase agents, initial encounter
T44.0X5S Adverse effect of anticholinesterase agents, sequela
T44.0X5D Adverse effect of anticholinesterase agents, subsequent encounter
T45.7X5A Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
T45.7X5S Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
T45.7X5D Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
T45.515A Adverse effect of anticoagulants, initial encounter
T45.515S Adverse effect of anticoagulants, sequela
T45.515D Adverse effect of anticoagulants, subsequent encounter
T47.6X5A Adverse effect of antidiarrheal drugs, initial encounter
T47.6X5S Adverse effect of antidiarrheal drugs, sequela
T47.6X5D Adverse effect of antidiarrheal drugs, subsequent encounter
T50.6X5A Adverse effect of antidotes and chelating agents, initial encounter
T50.6X5S Adverse effect of antidotes and chelating agents, sequela
T50.6X5D Adverse effect of antidotes and chelating agents, subsequent encounter
T36.7X5A Adverse effect of antifungal antibiotics, systemically used, initial encounter
T36.7X5S Adverse effect of antifungal antibiotics, systemically used, sequela
T36.7X5D Adverse effect of antifungal antibiotics, systemically used, subsequent encounter
T38.6X5A Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
T38.6X5S Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
T38.6X5D Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
T46.6X5A Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
T46.6X5S Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
T46.6X5D Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
T37.2X5A Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
T37.2X5S Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela
T37.2X5D Adverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter
T37.1X5A Adverse effect of antimycobacterial drugs, initial encounter
T37.1X5S Adverse effect of antimycobacterial drugs, sequela
T37.1X5D Adverse effect of antimycobacterial drugs, subsequent encounter
T45.1X5A Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X5S Adverse effect of antineoplastic and immunosuppressive drugs, sequela
T45.1X5D Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
T42.8X5A Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
42.8X5S Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
T42.8X5D Adverse effect of antiparkinsonism drugs and other central muscle-tonedepressants, subsequent encounter
T49.1X5A Adverse effect of antipruritics, initial encounter
T49.1X5S Adverse effect of antipruritics, sequela
T49.1X5D Adverse effect of antipruritics, subsequent encounter
T39.4X5A Adverse effect of antirheumatics, not elsewhere classified, initial encounter
T39.4X5S Adverse effect of antirheumatics, not elsewhere classified, sequela
T39.4X5D Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter
T45.525A Adverse effect of antithrombotic drugs, initial encounter
T45.525S Adverse effect of antithrombotic drugs, sequela
T45.525D Adverse effect of antithrombotic drugs, subsequent encounter
T38.2X5A Adverse effect of antithyroid drugs, initial encounter
T38.2X5S Adverse effect of antithyroid drugs, sequela
T38.2X5D Adverse effect of antithyroid drugs, subsequent encounter
T48.3X5A Adverse effect of antitussives, initial encounter
T48.3X5S Adverse effect of antitussives, sequela
T48.3X5D Adverse effect of antitussives, subsequent encounter
T46.8X5A Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
T46.8X5S Adverse effect of antivaricose drugs, including sclerosing agents, sequela
T46.8X5D Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
T37.5X5A Adverse effect of antiviral drugs, initial encounter
T37.5X5S Adverse effect of antiviral drugs, sequela
T37.5X5D Adverse effect of antiviral drugs, subsequent encounter
T50.5X5A Adverse effect of appetite depressants, initial encounter
T50.5X5S Adverse effect of appetite depressants, sequela
T50.5X5D Adverse effect of appetite depressants, subsequent encounter
T39.015A Adverse effect of aspirin, initial encounter
T39.015S Adverse effect of aspirin, sequela
T39.015D Adverse effect of aspirin, subsequent encounter
T42.3X5A Adverse effect of barbiturates, initial encounter
T42.3X5S Adverse effect of barbiturates, sequela
T42.3X5D Adverse effect of barbiturates, subsequent encounter
T42.4X5A Adverse effect of benzodiazepines, initial encounter
T42.4X5S Adverse effect of benzodiazepines, sequela
T42.4X5D Adverse effect of benzodiazepines, subsequent encounter
T44.7X5A Adverse effect of beta-adrenoreceptor antagonists, initial encounter
T44.7X5S Adverse effect of beta-adrenoreceptor antagonists, sequela
T44.7X5D Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter
T43.4X5A Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
T43.4X5S Adverse effect of butyrophenone and thiothixene neuroleptics, sequela
T43.4X5D Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
T43.615A Adverse effect of caffeine, initial encounter
T43.615S Adverse effect of caffeine, sequela
T43.615D Adverse effect of caffeine, subsequent encounter
T46.1X5A Adverse effect of calcium-channel blockers, initial encounter
T46.1X5S Adverse effect of calcium-channel blockers, sequela
T46.1X5D Adverse effect of calcium-channel blockers, subsequent encounter
T40.7X5A Adverse effect of cannabis (derivatives), initial encounter
T40.7X5S Adverse effect of cannabis (derivatives), sequela
T40.7X5D Adverse effect of cannabis (derivatives), subsequent encounter
T50.2X5A Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
T50.2X5S Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and otherdiuretics, sequela
T50.2X5D Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
T46.0X5A Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T46.0X5S Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
T46.0X5D Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T44.8X5A Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
T44.8X5S Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
T44.8X5D Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
T36.1X5A Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
T36.1X5S Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela
T36.1X5D Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
T36.2X5A Adverse effect of chloramphenicol group, initial encounter
T36.2X5S Adverse effect of chloramphenicol group, sequela
T36.2X5D Adverse effect of chloramphenicol group, subsequent encounter
T40.5X5A Adverse effect of cocaine, initial encounter
T40.5X5S Adverse effect of cocaine, sequela
T40.5X5D Adverse effect of cocaine, subsequent encounter
T46.3X5A Adverse effect of coronary vasodilators, initial encounter
T46.3X5S Adverse effect of coronary vasodilators, sequela
T46.3X5D Adverse effect of coronary vasodilators, subsequent encounter
T49.7X5A Adverse effect of dental drugs, topically applied, initial encounter
T49.7X5S Adverse effect of dental drugs, topically applied, sequela
T49.7X5D Adverse effect of dental drugs, topically applied, subsequent encounter
T50.8X5A Adverse effect of diagnostic agents, initial encounter
T50.8X5S Adverse effect of diagnostic agents, sequela
T50.8X5D Adverse effect of diagnostic agents, subsequent encounter
T47.5X5A Adverse effect of digestants, initial encounter
T47.5X5S Adverse effect of digestants, sequela
T47.5X5D Adverse effect of digestants, subsequent encounter
T50.4X5A Adverse effect of drugs affecting uric acid metabolism, initial encounter
T50.4X5S Adverse effect of drugs affecting uric acid metabolism, sequela
T50.4X5D Adverse effect of drugs affecting uric acid metabolism, subsequent encounter
T50.3X5A Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
T50.3X5S Adverse effect of electrolytic, caloric and water-balance agents, sequela
T50.3X5D Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
T47.7X5A Adverse effect of emetics, initial encounter
T47.7X5S Adverse effect of emetics, sequela
T47.7X5D Adverse effect of emetics, subsequent encounter
T49.3X5A Adverse effect of emollients, demulcents and protectants, initial encounter
T49.3X5S Adverse effect of emollients, demulcents and protectants, sequela
T49.3X5D Adverse effect of emollients, demulcents and protectants, subsequent encounter
T45.3X5A Adverse effect of enzymes, initial encounter
T45.3X5S Adverse effect of enzymes, sequela
T45.3X5D Adverse effect of enzymes, subsequent encounter
T48.4X5A Adverse effect of expectorants, initial encounter
T48.4X5S Adverse effect of expectorants, sequela
T48.4X5D Adverse effect of expectorants, subsequent encounter
T44.2X5A Adverse effect of ganglionic blocking drugs, initial encounter
T44.2X5S Adverse effect of ganglionic blocking drugs, sequela
T44.2X5D Adverse effect of ganglionic blocking drugs, subsequent encounter
T38.0X5A Adverse effect of glucocorticoids and synthetic analogues, initial encounter
T38.0X5S Adverse effect of glucocorticoids and synthetic analogues, sequela
T38.0X5D Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter
T45.625A Adverse effect of hemostatic drug, initial encounter
T45.625S Adverse effect of hemostatic drug, sequela
T45.625D Adverse effect of hemostatic drug, subsequent encounter
T47.0X5A Adverse effect of histamine H2-receptor blockers, initial encounter
T47.0X5S Adverse effect of histamine H2-receptor blockers, sequela
T47.0X5D Adverse effect of histamine H2-receptor blockers, subsequent encounter
T42.0X5A Adverse effect of hydantoin derivatives, initial encounter
T42.0X5S Adverse effect of hydantoin derivatives, sequela
T42.0X5D Adverse effect of hydantoin derivatives, subsequent encounter
T42.1X5A Adverse effect of iminostilbenes, initial encounter
T42.1X5S Adverse effect of iminostilbenes, sequela
T42.1X5D Adverse effect of iminostilbenes, subsequent encounter
T50.Z15A Adverse effect of immunoglobulin, initial encounter
T50.Z15S Adverse effect of immunoglobulin, sequela
T50.Z15D Adverse effect of immunoglobulin, subsequent encounter
T41.0X5A Adverse effect of inhaled anesthetics, initial encounter
T41.0X5S Adverse effect of inhaled anesthetics, sequela
T41.0X5D Adverse effect of inhaled anesthetics, subsequent encounter
T38.3X5A Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
T38.3X5S Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
T38.3X5D Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
T41.1X5A Adverse effect of intravenous anesthetics, initial encounter
T41.1X5S Adverse effect of intravenous anesthetics, sequela
T41.1X5D Adverse effect of intravenous anesthetics, subsequent encounter
T45.4X5A Adverse effect of iron and its compounds, initial encounter
T45.4X5S Adverse effect of iron and its compounds, sequela
T45.4X5D Adverse effect of iron and its compounds, subsequent encounter
T49.4X5A Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
T49.4X5S Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
T49.4X5D Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
T41.3X5A Adverse effect of local anesthetics, initial encounter
T41.3X5S Adverse effect of local anesthetics, sequela
T41.3X5D Adverse effect of local anesthetics, subsequent encounter
T49.0X5A Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
T49.0X5S Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
T49.0X5D Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
T49.2X5A Adverse effect of local astringents and local detergents, initial encounter
T49.2X5S Adverse effect of local astringents and local detergents, sequela
T49.2X5D Adverse effect of local astringents and local detergents, subsequent encounter
T50.1X5A Adverse effect of loop [high-ceiling] diuretics, initial encounter
T50.1X5S Adverse effect of loop [high-ceiling] diuretics, sequela
T50.1X5D Adverse effect of loop [high-ceiling] diuretics, subsequent encounter
No comments:
Post a Comment